Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001964306-24-000328
Filing Date
2024-08-28
Accepted
2024-08-28 17:12:36
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2860
  Complete submission text file 0001964306-24-000328.txt   4329
Mailing Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169
Business Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169 212-847-9841
Y-mAbs Therapeutics, Inc. (Subject) CIK: 0001722964 (see all company filings)

EIN.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38650 | Film No.: 241256623
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O Y-MABS THERAPEUTICS, INC. 230 PARK AVENUE, 33RD FLOOR NEW YORK NY 10169
Business Address
Lund-Hansen Torben (Reporting) CIK: 0001753134 (see all company filings)

Type: 144